It looks like the new patent press release hints of new technologies that will make isopet commercially viable which may mean cost-effective !
Reread it and you will see what I mean.
Richland WA, July 02, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Vivos today announced the filing of a patent application covering key aspects of its technology and propriety manufacturing process.
Vivos CEO, Dr. Mike Korenko stated “enhancing and extending our intellectual property protection is a core priority for Vivos. Over the past two years, we have made significant improvements in our manufacturing processes and corresponding enhancements in our underlying technology. These advancements represent proprietary knowledge in key areas, and we believe this additional patent protection will strengthen our competitive position. It is our intention to further extend this patent protection to several key countries within one year, as permitted under international patent laws and treaties.”
Dr. Korenko continued, “this most recent patent filing is an important next step for Vivos that builds upon our existing license agreement with Battelle Pacific Northwest Laboratory, our current US and International trademark protection and other proprietary practices. In accordance with patent law, this patent filing addresses new aspects of Vivos’ technology that have not yet been reported publicly or offered for sale. The timing of this filing is important given our plans to make IsoPet® commercially available in the near future. We intend to incorporate this enhanced technology as soon as possible for commercial sales of IsoPet®.
News 
Market Data 
Discover 
